Global Non-invasive Prenatal Testing Market Size and Forecast 2023-2032| F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc.,

The Non-invasive Prenatal Testing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2011-2022) and extends its insights into a ten-year forecast period (2024-2033).

Learn More On The Non-invasive Prenatal Testing Market:

https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

According to The Business Research Company’s Non-invasive Prenatal Testing Global Market Report 2024, The non-invasive prenatal testing market size has grown rapidly in recent years. It will grow from $4.73 billion in 2023 to $5.44 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to improved accuracy, reduced risk, increased maternal age, growing awareness, clinical guidelines.

The non-invasive prenatal testing market size is expected to see rapid growth in the next few years. It will grow to $9.43 billion in 2028 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to expanding test offerings, wider accessibility, rising maternal age, fetal anomaly detection, telemedicine and digital health. Major trends in the forecast period include expanded test panels, wider adoption of nipt, technological advancements, non-invasive fetal aneuploidy diagnosis (nifad).

High incidence rate of Down syndrome is one major factor driving non-invasive prenatal testing market with increase in average maternal age which has led to a concern on the safety about the growth of the fetus. Down syndrome is a chromosomal condition that occurs when an error in cell division results in an extra chromosome 21 and can affect the fetus cognitive ability and physical growth. The NIPT screening tests do not harm the mother or baby, carries no risk of miscarriage as they are non-invasive, and can detect more than 99% of cases of Down syndrome. According to National Down Syndrome Society and Centres for Disease control and Prevention, in the USA, 1 in every 700 babies are born with Down syndrome and 80% of children with Down syndrome are born to older mothers. The increased risk of having babies with Down syndrome among older women drives the growth of the non-invasive prenatal testing market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=2492&type=smp

The non-invasive prenatal testing market covered in this report is segmented –

1) By Type: Consumables; Instruments

2) By Application: Trisomy; Microdeletion; Genetics; Rh factor

3) By End User: Hospital; Diagnostic Labs

Subsegment: NGS Systems; PCR Instruments; Microarrays; Ultrasound Devices; Others(Centrifuges; UV Systems; Incubators; Microscopes); Assay Kits &Reagents; Disposables

The non-invasive prenatal testing market report table of contents includes:

1. Executive Summar

2. Non-invasive Prenatal Testing Market Characteristics

3. Non-invasive Prenatal Testing Market Trends And Strategies

4. Non-invasive Prenatal Testing Market – Macro Economic Scenario

5. Global Non-invasive Prenatal Testing Market Size and Growth

26. South America Non-invasive Prenatal Testing Market

27. Brazil Non-invasive Prenatal Testing Market

28. Middle East Non-invasive Prenatal Testing Market

29. Africa Non-invasive Prenatal Testing Market

30. Non-invasive Prenatal Testing Market Competitive Landscape And Company Profiles

Top Major Players: